Age Related Macular Degeneration (AMD) Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: A32EA9CFBACBEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Age Related Macular Degeneration (AMD) in Global, including the following market information:

Global Age Related Macular Degeneration (AMD) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Age Related Macular Degeneration (AMD) market was valued at 1348.9 million in 2021 and is projected to reach US$ 1836.1 million by 2028, at a CAGR of 4.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Wet AMD Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Age Related Macular Degeneration (AMD) include Bayer, F. HoffmannLa Roche, Regeneron, Novartis, Valeant and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Age Related Macular Degeneration (AMD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Age Related Macular Degeneration (AMD) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Age Related Macular Degeneration (AMD) Market Segment Percentages, by Type, 2021 (%)

• Wet AMD
• Dry AMD

Global Age Related Macular Degeneration (AMD) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Age Related Macular Degeneration (AMD) Market Segment Percentages, by Application, 2021 (%)

• Men
• Woman

Global Age Related Macular Degeneration (AMD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Age Related Macular Degeneration (AMD) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Age Related Macular Degeneration (AMD) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Age Related Macular Degeneration (AMD) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• F. HoffmannLa Roche
• Regeneron
• Novartis
• Valeant
• Pfizer

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Age Related Macular Degeneration (AMD) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Age Related Macular Degeneration (AMD) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AGE RELATED MACULAR DEGENERATION (AMD) OVERALL MARKET SIZE

2.1 Global Age Related Macular Degeneration (AMD) Market Size: 2021 VS 2028
2.2 Global Age Related Macular Degeneration (AMD) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Age Related Macular Degeneration (AMD) Players in Global Market
3.2 Top Global Age Related Macular Degeneration (AMD) Companies Ranked by Revenue
3.3 Global Age Related Macular Degeneration (AMD) Revenue by Companies
3.4 Top 3 and Top 5 Age Related Macular Degeneration (AMD) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Age Related Macular Degeneration (AMD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Age Related Macular Degeneration (AMD) Players in Global Market
  3.6.1 List of Global Tier 1 Age Related Macular Degeneration (AMD) Companies
  3.6.2 List of Global Tier 2 and Tier 3 Age Related Macular Degeneration (AMD) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Age Related Macular Degeneration (AMD) Market Size Markets, 2021 & 2028
  4.1.2 Wet AMD
  4.1.3 Dry AMD
4.2 By Type - Global Age Related Macular Degeneration (AMD) Revenue & Forecasts
  4.2.1 By Type - Global Age Related Macular Degeneration (AMD) Revenue, 2017-2022
  4.2.2 By Type - Global Age Related Macular Degeneration (AMD) Revenue, 2023-2028
  4.2.3 By Type - Global Age Related Macular Degeneration (AMD) Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Age Related Macular Degeneration (AMD) Market Size, 2021 & 2028
  5.1.2 Men
  5.1.3 Woman
5.2 By Application - Global Age Related Macular Degeneration (AMD) Revenue & Forecasts
  5.2.1 By Application - Global Age Related Macular Degeneration (AMD) Revenue, 2017-2022
  5.2.2 By Application - Global Age Related Macular Degeneration (AMD) Revenue, 2023-2028
  5.2.3 By Application - Global Age Related Macular Degeneration (AMD) Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Age Related Macular Degeneration (AMD) Market Size, 2021 & 2028
6.2 By Region - Global Age Related Macular Degeneration (AMD) Revenue & Forecasts
  6.2.1 By Region - Global Age Related Macular Degeneration (AMD) Revenue, 2017-2022
  6.2.2 By Region - Global Age Related Macular Degeneration (AMD) Revenue, 2023-2028
  6.2.3 By Region - Global Age Related Macular Degeneration (AMD) Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Age Related Macular Degeneration (AMD) Revenue, 2017-2028
  6.3.2 US Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.3.3 Canada Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.3.4 Mexico Age Related Macular Degeneration (AMD) Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Age Related Macular Degeneration (AMD) Revenue, 2017-2028
  6.4.2 Germany Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.4.3 France Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.4.4 U.K. Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.4.5 Italy Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.4.6 Russia Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.4.7 Nordic Countries Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.4.8 Benelux Age Related Macular Degeneration (AMD) Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Age Related Macular Degeneration (AMD) Revenue, 2017-2028
  6.5.2 China Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.5.3 Japan Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.5.4 South Korea Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.5.5 Southeast Asia Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.5.6 India Age Related Macular Degeneration (AMD) Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Age Related Macular Degeneration (AMD) Revenue, 2017-2028
  6.6.2 Brazil Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.6.3 Argentina Age Related Macular Degeneration (AMD) Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Age Related Macular Degeneration (AMD) Revenue, 2017-2028
  6.7.2 Turkey Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.7.3 Israel Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.7.4 Saudi Arabia Age Related Macular Degeneration (AMD) Market Size, 2017-2028
  6.7.5 UAE Age Related Macular Degeneration (AMD) Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer
  7.1.1 Bayer Corporate Summary
  7.1.2 Bayer Business Overview
  7.1.3 Bayer Age Related Macular Degeneration (AMD) Major Product Offerings
  7.1.4 Bayer Age Related Macular Degeneration (AMD) Revenue in Global Market (2017-2022)
  7.1.5 Bayer Key News
7.2 F. HoffmannLa Roche
  7.2.1 F. HoffmannLa Roche Corporate Summary
  7.2.2 F. HoffmannLa Roche Business Overview
  7.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Major Product Offerings
  7.2.4 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue in Global Market (2017-2022)
  7.2.5 F. HoffmannLa Roche Key News
7.3 Regeneron
  7.3.1 Regeneron Corporate Summary
  7.3.2 Regeneron Business Overview
  7.3.3 Regeneron Age Related Macular Degeneration (AMD) Major Product Offerings
  7.3.4 Regeneron Age Related Macular Degeneration (AMD) Revenue in Global Market (2017-2022)
  7.3.5 Regeneron Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Age Related Macular Degeneration (AMD) Major Product Offerings
  7.4.4 Novartis Age Related Macular Degeneration (AMD) Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Valeant
  7.5.1 Valeant Corporate Summary
  7.5.2 Valeant Business Overview
  7.5.3 Valeant Age Related Macular Degeneration (AMD) Major Product Offerings
  7.5.4 Valeant Age Related Macular Degeneration (AMD) Revenue in Global Market (2017-2022)
  7.5.5 Valeant Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Age Related Macular Degeneration (AMD) Major Product Offerings
  7.6.4 Pfizer Age Related Macular Degeneration (AMD) Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Age Related Macular Degeneration (AMD) Market Opportunities & Trends in Global Market
Table 2. Age Related Macular Degeneration (AMD) Market Drivers in Global Market
Table 3. Age Related Macular Degeneration (AMD) Market Restraints in Global Market
Table 4. Key Players of Age Related Macular Degeneration (AMD) in Global Market
Table 5. Top Age Related Macular Degeneration (AMD) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Age Related Macular Degeneration (AMD) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Age Related Macular Degeneration (AMD) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Age Related Macular Degeneration (AMD) Product Type
Table 9. List of Global Tier 1 Age Related Macular Degeneration (AMD) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Age Related Macular Degeneration (AMD) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Age Related Macular Degeneration (AMD) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Age Related Macular Degeneration (AMD) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Age Related Macular Degeneration (AMD) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Age Related Macular Degeneration (AMD) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Age Related Macular Degeneration (AMD) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Age Related Macular Degeneration (AMD) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Corporate Summary
Table 31. Bayer Age Related Macular Degeneration (AMD) Product Offerings
Table 32. Bayer Age Related Macular Degeneration (AMD) Revenue (US$, Mn), (2017-2022)
Table 33. F. HoffmannLa Roche Corporate Summary
Table 34. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product Offerings
Table 35. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue (US$, Mn), (2017-2022)
Table 36. Regeneron Corporate Summary
Table 37. Regeneron Age Related Macular Degeneration (AMD) Product Offerings
Table 38. Regeneron Age Related Macular Degeneration (AMD) Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Age Related Macular Degeneration (AMD) Product Offerings
Table 41. Novartis Age Related Macular Degeneration (AMD) Revenue (US$, Mn), (2017-2022)
Table 42. Valeant Corporate Summary
Table 43. Valeant Age Related Macular Degeneration (AMD) Product Offerings
Table 44. Valeant Age Related Macular Degeneration (AMD) Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Age Related Macular Degeneration (AMD) Product Offerings
Table 47. Pfizer Age Related Macular Degeneration (AMD) Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Age Related Macular Degeneration (AMD) Segment by Type in 2021
Figure 2. Age Related Macular Degeneration (AMD) Segment by Application in 2021
Figure 3. Global Age Related Macular Degeneration (AMD) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Age Related Macular Degeneration (AMD) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Age Related Macular Degeneration (AMD) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Age Related Macular Degeneration (AMD) Revenue in 2021
Figure 8. By Type - Global Age Related Macular Degeneration (AMD) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Age Related Macular Degeneration (AMD) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Age Related Macular Degeneration (AMD) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Age Related Macular Degeneration (AMD) Revenue Market Share, 2017-2028
Figure 12. US Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Age Related Macular Degeneration (AMD) Revenue Market Share, 2017-2028
Figure 16. Germany Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 17. France Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Age Related Macular Degeneration (AMD) Revenue Market Share, 2017-2028
Figure 24. China Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 28. India Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Age Related Macular Degeneration (AMD) Revenue Market Share, 2017-2028
Figure 30. Brazil Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) Revenue Market Share, 2017-2028
Figure 33. Turkey Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Regeneron Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Valeant Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)